First ever pill to beat HIV under FDA considerationMay 10th, 2012 - 6:17 pm ICT by IANS
London, May 10 (IANS) Truvada, the first ever pill to beat HIV — a breakthrough in the 30-year-old war against AIDS epidemic — is under active consideration of the US Food and Drug Administration (FDA) for approval.
Currently used to treat HIV, tests have shown Truvada to be effective in protecting healthy people too. The FDA concluded a pill daily could stave off “infection with a serious and life-threatening illness that requires lifelong treatment”.
A panel of FDA advisers will consider the review when it votes on whether Truvada, created by California-based Gilead Sciences, should be approved as a preventative treatment for the HIV afflicted. Gilead has marketed Truvada since 2004 as a treatment for the HIV infected.
An estimated 1.2 million Americans suffer from HIV, which unless treated with antiviral drugs, develops into Acquired Immuno deficiency Syndrome (AIDS), a condition which renders the body defenceless against infections, the Daily Mail reports.
There have been no other drugs proven to prevent HIV and a vaccine is believed to be decades away. Truvada is a combination of two older HIV drugs, Emtriva and Viread.
Doctors usually prescribe the medication as part of a drug cocktail that makes it harder for the virus to reproduce. Patients with low viral levels have reduced symptoms and are far less likely to develop AIDS.
Researchers first reported that Truvada could prevent people from contracting HIV in 2010. A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 44 percent, when accompanied by condoms and counselling.
A separate study found that Truvada reduced infection by 75 percent in heterosexual couples in which one partner was infected with HIV and the other was not.
Since Truvada is already in the market to manage HIV, some doctors already prescribe it as a preventive measure. But an approval from the FDA would allow Gilead Sciences to formally market the drug for that use.
“If we’re going to reduce the more than 50,000 new HIV infections in this country each year, we need to increase the available options for people,” AIDS United’s vice-president Ronald Johnson said.
- US approves drug to prevent HIV infection - Jul 17, 2012
- HIV drug now available as oral powder for children - Jan 29, 2012
- HIV pill could lessen infection risk among healthy gays - Nov 26, 2010
- Latest Aids Pill Undergoing Trial Could Be The Next Medical Revolution - Apr 06, 2010
- Study on AIDS prevention pill paused - Apr 19, 2011
- US approves new HIV treatment - May 21, 2011
- Gilead's model to enhance availability of anti-AIDS drug - Feb 22, 2009
- AIDS Breakthrough Discovered For Women - Jul 20, 2010
- Cure for AIDS a step closer - Jul 26, 2012
- FDA Says 'New Morning After Pill' is Effective and Safe - Jun 15, 2010
- Study: Prozac is a multi-use drug; helps in stroke recovery too - Jan 11, 2011
- Integrate Hepatitis C testing with HIV: NGOs - Oct 21, 2011
- Popping HIV pill 'cuts risk of infection by 44pc' - Nov 24, 2010
- Preventive use of breast cancer drugs urged - Mar 28, 2011
- Widely used HIV drug could help prevent cervical cancer - May 04, 2011
Tags: aids epidemic, aids researchers, antiviral drugs, contracting hiv, daily mail, drug cocktail, emtriva, fda advisers, food and drug administration, food and drug administration fda, heterosexual couples, hiv drugs, hiv tests, lifelong treatment, mail reports, preventative treatment, truvada, us food and drug administration, viral levels, viread